FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

724144006: Embryofetopathy caused by methimazole (disorder)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3431096018 Embryofetopathy caused by methimazole (disorder) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3431097010 Methimazole embryofetopathy en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3431098017 Embryofetopathy caused by methimazole en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5403247011 A teratogenic embryofetopathy that results from maternal exposure to methimazole (MMI; or the parent compound carbimazole) in the first trimester of pregnancy. MMI is an antithyroid thionamide drug used for the treatment of Graves' disease. In the infant, MMI may result in choanal atresia, esophageal atresia, omphalocele, omphalomesenteric duct anomalies, congenital heart disease (such as ventricular septal defect), renal system malformations and aplasia cutis. Additional features that may be observed include facial dysmorphism (short upslanting palpebral fissures, a broad nasal bridge with a small nose and a broad forehead) and athelia/hypothelia. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
5403248018 A teratogenic embryofetopathy that results from maternal exposure to methimazole (MMI; or the parent compound carbimazole) in the first trimester of pregnancy. MMI is an antithyroid thionamide drug used for the treatment of Graves' disease. In the infant, MMI may result in choanal atresia, oesophageal atresia, omphalocele, omphalomesenteric duct anomalies, congenital heart disease (such as ventricular septal defect), renal system malformations and aplasia cutis. Additional features that may be observed include facial dysmorphism (short upslanting palpebral fissures, a broad nasal bridge with a small nose and a broad forehead) and athelia/hypothelia. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
3431096018 Embryofetopathy caused by methimazole (disorder) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3431097010 Methimazole embryofetopathy en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3431098017 Embryofetopathy caused by methimazole en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3431099013 A teratogenic embryofetopathy that results from maternal exposition to methimazole in the first trimester of pregnancy. Methimazole is an antithyroid thionamide drug used for the treatment of Graves' disease. In the infant, methimazole may result in choanal atresia, esophageal atresia, omphalocele, omphalomesenteric duct anomalies, congenital heart disease (such as ventricular septal defect), renal system malformations and aplasia cutis. Additional features that may be observed include facial dysmorphism (short up slanting palpebral fissures, a broad nasal bridge with a small nose and a broad forehead) and athelia. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
3431100017 A teratogenic embryofetopathy that results from maternal exposition to methimazole in the first trimester of pregnancy. Methimazole is an antithyroid thionamide drug used for the treatment of Graves' disease. In the infant, methimazole may result in choanal atresia, oesophageal atresia, omphalocele, omphalomesenteric duct anomalies, congenital heart disease (such as ventricular septal defect), renal system malformations and aplasia cutis. Additional features that may be observed include facial dysmorphism (short up slanting palpebral fissures, a broad nasal bridge with a small nose and a broad forehead) and athelia. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
5403247011 A teratogenic embryofetopathy that results from maternal exposure to methimazole (MMI; or the parent compound carbimazole) in the first trimester of pregnancy. MMI is an antithyroid thionamide drug used for the treatment of Graves' disease. In the infant, MMI may result in choanal atresia, esophageal atresia, omphalocele, omphalomesenteric duct anomalies, congenital heart disease (such as ventricular septal defect), renal system malformations and aplasia cutis. Additional features that may be observed include facial dysmorphism (short upslanting palpebral fissures, a broad nasal bridge with a small nose and a broad forehead) and athelia/hypothelia. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
5403248018 A teratogenic embryofetopathy that results from maternal exposure to methimazole (MMI; or the parent compound carbimazole) in the first trimester of pregnancy. MMI is an antithyroid thionamide drug used for the treatment of Graves' disease. In the infant, MMI may result in choanal atresia, oesophageal atresia, omphalocele, omphalomesenteric duct anomalies, congenital heart disease (such as ventricular septal defect), renal system malformations and aplasia cutis. Additional features that may be observed include facial dysmorphism (short upslanting palpebral fissures, a broad nasal bridge with a small nose and a broad forehead) and athelia/hypothelia. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
3449151001000113 Methimazol-Embryofetopathie de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
6086001000241119 embryofœtopathie causée par le méthimazole fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
6086011000241117 embryofœtopathie causée par le thiamazole fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
6086001000241119 embryofœtopathie causée par le méthimazole fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
6086011000241117 embryofœtopathie causée par le thiamazole fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
3449151001000113 Methimazol-Embryofetopathie de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Methimazole embryofetopathy Is a trouble causé par un médicament false Inferred relationship Existential restriction modifier (core metadata concept)
Methimazole embryofetopathy Is a Congenital malformation syndrome due to known exogenous cause false Inferred relationship Existential restriction modifier (core metadata concept)
Methimazole embryofetopathy Is a Disorder of fetal structure false Inferred relationship Existential restriction modifier (core metadata concept)
Methimazole embryofetopathy Associated morphology anomalie du développement false Inferred relationship Existential restriction modifier (core metadata concept) 1
Methimazole embryofetopathy Causative agent (attribute) Methimazole true Inferred relationship Existential restriction modifier (core metadata concept) 1
Methimazole embryofetopathy Occurrence Congenital true Inferred relationship Existential restriction modifier (core metadata concept) 1
Methimazole embryofetopathy Finding site Fetal structure true Inferred relationship Existential restriction modifier (core metadata concept) 1
Methimazole embryofetopathy Pathological process (attribute) Pathological developmental process (qualifier value) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Methimazole embryofetopathy Associated morphology Morphologically abnormal structure true Inferred relationship Existential restriction modifier (core metadata concept) 1
Methimazole embryofetopathy Is a Congenital malformation syndrome true Inferred relationship Existential restriction modifier (core metadata concept)
Methimazole embryofetopathy Is a trouble selon la localisation corporelle false Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Component annotation with string value reference set (foundation metadata concept)

Back to Start